BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 45 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 52,257,000 | $39,745,106 | 8.72% |
| Context Capital Management, LLC | 32,083 | $24,052 | 1.93% |
| BRAIDWELL LP | 67,294,000 | $50,470,500 | 1.60% |
| DeepCurrents Investment Group LLC | 17,855,000 | $13,514,056 | 0.59% |
| Aequim Alternative Investments LP | 20,000,000 | $15,000,000 | 0.57% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,488,000 | $22,116,000 | 0.51% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $3,750,375 | 0.51% |
| ARISTEIA CAPITAL, L.L.C. | 25,280,000 | $18,960,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 8,217,000 | $6,121,665 | 0.50% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,604,000 | $3,430,520 | 0.49% |
| LINDEN ADVISORS LP | 55,810,000 | $41,974,462 | 0.43% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 13,000,000 | $9,865,180 | 0.41% |
| Segantii Capital Management Ltd | 10,000,000 | $7,642,559 | 0.27% |
| CSS LLC/IL | 5,000,000 | $3,725,000 | 0.24% |
| Laurion Capital Management LP | 19,100,000 | $14,494,226 | 0.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,485,000 | $4,863,750 | 0.07% |
| Verition Fund Management LLC | 5,709 | $4,281,750 | 0.05% |
| D. E. Shaw & Co., Inc. | 52,250,000 | $39,237,152 | 0.04% |
| Calamos Advisors LLC | 10,000,000 | $7,605,700 | 0.04% |
| Point72 Asset Management, L.P. | 17,500,000 | $13,143,169 | 0.04% |
This page lists BRIDGEBIO PHARMA INC's shareholders in Q3 2023. To view BRIDGEBIO PHARMA INC's shareholder history, click here.